Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
18.95
-0.07 (-0.37%)
At close: Mar 13, 2026, 4:00 PM EDT
18.93
-0.02 (-0.11%)
After-hours: Mar 13, 2026, 5:17 PM EDT

Eton Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-6.68-3.82-0.94-9.02-1.96-27.97
Depreciation & Amortization
3.381.150.91.770.460.65
Stock-Based Compensation
5.173.173.144.223.382.58
Other Adjustments
5.291.180.180.19-0.41.39
Change in Receivables
-8.66-3.12-1.563.62-5.420.43
Changes in Inventories
-5.58-1.31-0.35-0.010.69-0.86
Changes in Accounts Payable
11.572.320.05-0.01-0.571.77
Changes in Accrued Expenses
12.614.725.32.220.12-0.3
Changes in Other Operating Activities
4.21-3.310.091.84-1.03-0.02
Operating Cash Flow
21.310.976.824.82-4.72-22.35
Operating Cash Flow Growth
904.72%-85.78%41.36%---
Capital Expenditures
-0.3-0.03--0.04-0.01-0.05
Sale of Property, Plant & Equipment
----0.7-
Purchases of Intangible Assets
-8.12-9.99-0.78-2.75-3.25-
Payments for Business Acquisitions
-30-30----
Investing Cash Flow
-38.42-40.01-0.78-2.79-2.56-0.05
Long-Term Debt Issued
25.3125.31---2.48
Long-Term Debt Repaid
--1.16-1.16-0.39-0.15-
Net Long-Term Debt Issued (Repaid)
25.3124.15-1.16-0.39-0.152.48
Issuance of Common Stock
8.528.440.380.250.5429.15
Repurchase of Common Stock
---0.18---
Net Common Stock Issued (Repurchased)
8.528.440.20.250.5429.15
Financing Cash Flow
33.9732.59-0.96-0.130.3931.63
Net Cash Flow
16.86-6.455.081.9-6.899.23
Free Cash Flow
21.010.946.824.78-4.73-22.4
Free Cash Flow Growth
2128.42%-86.16%42.48%---
FCF Margin
29.89%2.42%21.54%22.51%-21.67%-57425.64%
Free Cash Flow Per Share
0.790.040.270.19-0.19-1.07
Levered Free Cash Flow
44.5323.873.9-3.63-2.44-24.31
Unlevered Free Cash Flow
23.30.955.22-2.48-1.83-25.92
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q